Navigation Links
Leukemia Drug Proves Safe and Effective Over the Long Term
Date:11/7/2007

ere reported in study participants, only four cases were considered to be drug-related. During the study, 35 patients discontinued the drug because of adverse events or abnormal test results.

"About half of the patients on the study continue to receive imatinib and 40 percent are in complete cytogenetic response," said Dr. Kantarjian. "No long-term new toxicities have been observed. In particular, the drug-related cardiac toxicity, which was reported to be of concern last year, was quite rare."

This clinical trial was the basis for the first approval of imatinib for CML, which has since become the standard of care for the disease.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Blood, the official journal of the American Society of Hematology, is the most cited peer-reviewed publication in the field. Blood is issued to Society members and other subscribers twice per month, available in print and online at http://www.bloodjournal.org.


'/>"/>
SOURCE American Society of Hematology
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
4. September is Leukemia, Lymphoma and Myeloma Awareness Month
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
7. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
8. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
9. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
10. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 Instacare Corp. (OTC Bulletin Board: ... life-enhancing prescription drugs and diagnostics and at home ... leading developer and provider of e-health technologies and ... today that as part of the preparation of ... to add two new Directors and has rejected, ...
(Date:12/17/2009)... -- Express Scripts, Inc. (Nasdaq: ESRX ... management companies in North America, announced today ... association of seizure risk among epilepsy patients ... The study found no evidence that switching ... generic substitution, was associated with increased emergency ...
(Date:12/17/2009)... BioTherapeutics, Inc. (NYSE-Amex: PLX ) today announced ... Sales and Commercial Affairs. In this newly ... responsible for all commercial activities, including pre-launch and ... the collaboration agreement between the Company and Pfizer ... emerge from the Company,s pipeline. Ms. Lauterbach ...
Breaking Medicine Technology:Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers 50417 1Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers 50417 2Blue Shield of California Makes Understanding Health Care Issues Easier for Consumers 50417 3Hospira Announces New Contract With MedAssets for Intravenous Solutions Renewal of Infusion Devices Agreement 12851 1Hospira Announces New Contract With MedAssets for Intravenous Solutions Renewal of Infusion Devices Agreement 12851 2Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 1Bion Announces Approval of New U S Patent that Broadens Protection for the Companys Livestock Waste Environmental Treatment Processes 12848 2
... Abeome Corporation, a,Georgia-based biotech company, announced today ... a collaboration with Cato Research Ltd.,its global ... collaboration will help support continued development of ... technology vastly improves the development of,monoclonal antibodies ...
... as the Clinical Gold Standard ... from Decision Resources, WALTHAM, Mass., July 15 ... and advisory firms focusing on pharmaceutical and,healthcare issues, ... of depressive mood episodes in patients who suffer ...
Other Medicine Technology:Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Current and Emerging Drugs Continue to Struggle for Patient Share in the Treatment of Major Depressive Disorder 2
(Date:12/17/2009)... Dec. 17 The Department of Justice ... state of New York have entered into settlement ... allegations that they submitted false claims to the ... The New York Medicaid program provides coverage for ... valid certificates showing that they received proper training. ...
(Date:12/17/2009)... Life" in Majority Leader,s Revisions to Senate Health ... 17 Americans United for Life Action ... to Senate Majority Leader Harry Reid as he ... revisions to a bill - to the Senate ... to include "specific language that ensures your legislation ...
(Date:12/17/2009)... ,Hopenhagen, the city is calling itself, ... international conference on climate change. Narconon has its ... of the worldwide Narconon drug education ... from climate change. But the streets thrum with ... by with flashing blue lights - a youth ...
(Date:12/17/2009)... not be beneficial , , THURSDAY, Dec. 17 (HealthDay News) ... the immediate effect of the fish oil fatty acids ... increase in blood fats and the molecules that help ... that the acute response has some potentially negative effects ... long-term intake," said Lindsay E. Robinson, an associate professor ...
(Date:12/17/2009)... fall down on prevention, experts say , , THURSDAY, ... surgeons are getting better at treating heart attacks ... ignoring the basic rules for preventing them, according ... , Topping the list: too little exercise, too ... adults surveyed last year reported no activity vigorous ...
Breaking Medicine News(10 mins):Health News:Three New York City Home Health Agencies Pay $9.7 Million to the United States to Settle False Claims Act Claims 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Save the Planet. Stop Smoking Dope, Says Narconon 2Health News:Could Omega-3s Boost Blood Fat Levels? 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
... support program with the goal to help healthcare professionals optimize outcomes ... ... (PRWEB) January 29, 2009 -- Though rare, gastrointestinal stromal tumors (GISTs) ... with an estimated 3,300 to 6,000 new cases reported each year ...
... message during the big gameMINNEAPOLIS, Jan. 29 The ... ads as it is for the actual football game. ... from ClearWay Minnesota that somberly reminds Minnesotans that "we ... and health consequences of tobacco use are explored though ...
... Researchers from Boston University School of Medicine (BUSM) and ... have found that children born more than three months premature, ... the modified checklist for autism in toddlers (M-CHAT). Children ... for developing autism. These findings appear in the January ...
... A new way of making LEDs could see household ... years. , Gallium Nitride (GaN), a man-made semiconductor ... light but uses very little electricity. Until now high ... wide spread use in homes and offices. , ...
... years; lawmakers demand criminal probe after U.S. health officials ... 2007 and 2008. , , WEDNESDAY, Jan. 28 (HealthDay News) ... late Wednesday for all peanut products made over the ... the current salmonella outbreak. , The recall was initiated ...
... Jan. 28 Consumer Watchdog warned that the move by ... California will lead to degradation of the quality of patient ... the interest of nursing home owners over patients.The current agreements ... protect the right of caregivers to blow the whistle on ...
Other Medicine News:Health News:Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors 2Health News:Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors 3Health News:New Super Bowl Ad Reminds Minnesotans: 'We All Pay the Price for Tobacco' 2Health News:New Super Bowl Ad Reminds Minnesotans: 'We All Pay the Price for Tobacco' 3Health News:Study finds preemies more likely to score positive 2Health News:Low-cost LEDs to slash household electric bills 2Health News:All Products at Georgia Peanut Plant Recalled 2Health News:All Products at Georgia Peanut Plant Recalled 3Health News:All Products at Georgia Peanut Plant Recalled 4
Inquire...
... Array Multifocal IOL was designed to provide ... from glasses in most situations. While distance ... similar to that of a single vision ... better and about 19 in 20 people ...
The Pach IV is the premier product for cornea thickness measurement in conjunction with Glaucoma screening....
... The Zeus Scientific, Inc. ... for the qualitative and quantitative ... human serum by the indirect ... assay can determine or confirm ...
Medicine Products: